Roundtable: Medical matters - product liability in the life sciences
Advances in medical science have created new opportunities and challenges for product liability insurers and policyholders, but is either party ready for what lies ahead?
As the life sciences sector continues to make major medical breakthroughs, product liability insurers are finding their services growing increasingly necessary, perhaps more so in light of the Poly
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe
You are currently unable to print this content. Please contact info@postonline.co.uk to find out more.
You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@postonline.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@postonline.co.uk
More on Broker
Inflexion acquires Ascend in regional broking push
Private equity firm Inflexion has bought Essex-based broker Ascend, with the two announcing the launch of a new broking platform focussed on the regional broking market.
Throwback Thursday: Thatcher’s honours; General Accident boycott
Insurance Post’s Throwback Thursday steps back in time to January 1991 to remind you what was going on this week in insurance history when former prime minister Margaret Thatcher honoured insurance men and brokers’ plans to teach General Accident a lesson were thwarted.
Ex-Esure CEO re-emerges as Jensten chair
Former Esure CEO David McMillan has been appointed non-executive chair of the Jensten Group board.
Big Interview: Robert Kennedy, Howden
Howden’s UK and Ireland CEO Robert Kennedy shares his growth plans for the business and explains why the broking giant won’t abandon the high street any time soon.
Howden’s Kennedy says regulation may have ‘gone too far'
Howden UK & Ireland CEO Robert Kennedy has told Insurance Post he believes regulation has “gone too far” in certain places, and could be stifling innovation.
Howden CEO reveals M&A plus growth plans
Robert Kennedy, CEO of Howden UK and Ireland, has told Insurance Post its parent group aims to hit £10bn of global revenue by 2030.
Diary of an Insurer: Gallagher’s Cheryl Phillips
Cheryl Phillips, regional managing director of the South West for Gallagher, criss-crosses the region, integrates new teams, catches ups with clients, spots talent and enjoys a well-earned office Christmas party.
Broker Forecast for 2026
Brokers are bracing for a soft but fiercely competitive market in 2026 shaped by economic pressures, rapid digitalisation and widening technological divides.